Cambrian BioPharma Inc, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), sold 35,803 shares at $11.40 ($398K) on 2025-12-05, disclosed to the SEC on 2025-12-08.
Open-market sale of $398k SNSE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.06 | 5,000 | $45K | 11.4% |
| 2 | $11.40 | 14,508 | $165K | 41.5% |
| 3 | $11.40 | 14,508 | $165K | 41.5% |
| 4 | $12.29 | 1,745 | $21K | 5.4% |
| 5 | $13.16 | 42 | $553 | 0.1% |
| Total | $11.12 avg | 35,803 |
| $398K |
| 100% |
| Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |
| SNSE | BUY | 2022-03-02 | $4K | — | Filing → |